皮肤癣菌病的新型疗法
Newer Therapies in Dermatophytosis.
作者信息
Poddar Shreya, Das Anupam, Hay Roderick James, Wollina Uwe
机构信息
From the Department of Dermatology, IPGMER and SSKM, Kolkata, West Bengal, India.
Department of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
出版信息
Indian J Dermatol. 2023 Sep-Oct;68(5):515-519. doi: 10.4103/ijd.ijd_829_23.
Abstract
With the advent of newer drugs and formulations, the armamentarium to combat dermatophytosis is ever-expanding. However, we must be rational and scientific when choosing the drugs. This review is an attempt to summarise the recently approved and upcoming therapeutic options for dermatophytosis.
摘要
随着更新型药物和制剂的出现，用于对抗皮肤癣菌病的武器库不断扩大。然而，我们在选择药物时必须理性且科学。本综述旨在总结近期获批以及即将出现的皮肤癣菌病治疗选择。
相似文献
1
Newer Therapies in Dermatophytosis.
Indian J Dermatol. 2023 Sep-Oct;68(5):515-519. doi: 10.4103/ijd.ijd_829_23.
2
IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
Indian Dermatol Online J. 2023 Dec 1;15(1):1-7. doi: 10.4103/idoj.idoj_668_22. eCollection 2024 Jan-Feb.
3
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
Drugs Context. 2023 Jan 9;12. doi: 10.7573/dic.2022-8-1. eCollection 2023.
4
An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.
Clin Cosmet Investig Dermatol. 2021 Sep 27;14:1367-1376. doi: 10.2147/CCID.S326642. eCollection 2021.
5
Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
Indian Dermatol Online J. 2021 Jan 16;12(1):1-5. doi: 10.4103/idoj.IDOJ_618_20. eCollection 2021 Jan-Feb.
6
Comparative Efficacy and Safety of Super-Bioavailable Itraconazole-130 mg Once Daily in Obese and Non-Obese Patients of Glabrous Tinea.
Indian Dermatol Online J. 2023 Oct 5;14(6):839-843. doi: 10.4103/idoj.idoj_120_23. eCollection 2023 Nov-Dec.
7
Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea.
Infect Drug Resist. 2023 Apr 24;16:2409-2416. doi: 10.2147/IDR.S407946. eCollection 2023.
8
Superficial Dermatophytosis across the World's Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges.
ACS Omega. 2023 Aug 22;8(35):31575-31599. doi: 10.1021/acsomega.3c01988. eCollection 2023 Sep 5.
9
Efficacy and Safety of Adding Low-Dose Isotretinoin to Itraconazole in the Treatment of Chronic Recurrent Dermatophytosis among Sample of Iraqi Patients: An Open-Labelled Therapeutic Clinical Comparative Study.
Indian J Dermatol. 2022 Sep-Oct;67(5):624. doi: 10.4103/ijd.ijd_332_22.
10
Comparison of two systemic antifungal agents, itraconazole and terbinafine, for the treatment of dermatophytosis in European hedgehogs (Erinaceus europaeus).
Vet Dermatol. 2016 Dec;27(6):500-e133. doi: 10.1111/vde.12378. Epub 2016 Sep 12.
引用本文的文献
1
[Development of resistance in skin fungi : Molecular mechanisms, antifungal resistance assays, risk factors, and diagnostic regime-challenges for medical treatment].
Dermatologie (Heidelb). 2025 Jun 24. doi: 10.1007/s00105-025-05527-8.
2
Evaluation of the efficacy of novel topical antifungal agents against dermatophytes in North India: A prospective study.
Curr Med Mycol. 2024 Nov 15;10. doi: 10.22034/cmm.2024.345268.1562. eCollection 2024.
本文引用的文献
1
The emergence of Trichophyton indotineae: Implications for clinical practice.
Int J Dermatol. 2023 Jul;62(7):857-861. doi: 10.1111/ijd.16362. Epub 2022 Jul 22.
2
Efinaconazole in Onychomycosis.
Am J Clin Dermatol. 2022 Mar;23(2):207-218. doi: 10.1007/s40257-021-00660-1. Epub 2021 Dec 13.
3
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Int J Dermatol. 2022 Dec;61(12):1431-1441. doi: 10.1111/ijd.15999. Epub 2021 Dec 9.
4
Super Bioavailable Itraconazole and Its Place and Relevance in Recalcitrant Dermatophytosis: Revisiting Skin Levels of Itraconazole and Minimum Inhibitory Concentration Data.
Indian Dermatol Online J. 2021 Jan 16;12(1):1-5. doi: 10.4103/idoj.IDOJ_618_20. eCollection 2021 Jan-Feb.
5
Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources.
Pharmaceuticals (Basel). 2020 Sep 15;13(9):248. doi: 10.3390/ph13090248.
6
Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.
Dermatol Ther (Heidelb). 2020 Oct;10(5):917-929. doi: 10.1007/s13555-020-00420-9. Epub 2020 Jul 23.
7
Antifungal effects of statins.
Pharmacol Ther. 2020 Apr;208:107483. doi: 10.1016/j.pharmthera.2020.107483. Epub 2020 Jan 15.
8
8-Hydroxyquinoline-5-sulfonamides are promising antifungal candidates for the topical treatment of dermatomycosis.
J Appl Microbiol. 2020 Apr;128(4):1038-1049. doi: 10.1111/jam.14545. Epub 2019 Dec 20.
9
Non-thermal atmospheric plasma treatment of onychomycosis in an in vitro human nail model.
Mycoses. 2020 Feb;63(2):225-232. doi: 10.1111/myc.13030. Epub 2019 Dec 15.
10
Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
Recent Pat Drug Deliv Formul. 2019;13(3):203-218. doi: 10.2174/1872211313666191030155837.
Zotero 插件